Adipose derived stem cells isolated from omentum: A novel source of chemokines for ovarian cancer growth

Journal of Cancer Research and Therapeutics

Volumn 10, Issue 1, 2014, Pages 159-164

  Rezaeifard, Somayeh ^a,b   Razmkhah, Mahboobeh ^a   Robati, Minoo ^c   Momtahan, Mozhdeh ^c   Ghaderi, Abbas ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Adipose derive stem cells; omentum; ovarian cancer; ovarian cyst

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR3; ENDOGLIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; STROMAL CELL DERIVED FACTOR 1; CALCIUM; CHEMOKINE RECEPTOR; MEMBRANE ANTIGEN;

ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; CANCER GROWTH; CELL ISOLATION; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; OVARY CANCER; OVARY CYST; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADIPOSE TISSUE; BONE DEVELOPMENT; CANCER STAGING; CELL DIFFERENTIATION; CYTOLOGY; GENE EXPRESSION; GENETICS; IMMUNOPHENOTYPING; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; OMENTUM; OVARY TUMOR; PATHOLOGY; PRIMARY CELL CULTURE; STEM CELL; YOUNG ADULT;

ADIPOSE TISSUE; ADULT; ANTIGENS, SURFACE; CALCIUM; CELL DIFFERENTIATION; CHEMOKINES; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOPLASM STAGING; OMENTUM; OSTEOGENESIS; OVARIAN NEOPLASMS; PRIMARY CELL CULTURE; RECEPTORS, CHEMOKINE; STEM CELLS; YOUNG ADULT;

EID: 84899669084     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.131451     Document Type: Article

References (34)

1. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, et al. Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 2011;121:3206-19.
2. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008;8:726-36.
3. Hou F, Huang JM, Zhang R, Li L, Li G. An experimental study on the regulation of bone marrow-derived mesenchymal stem cells through indoleamine 2,3-dioxygenase signaling pathway by thymosin α1 for improving the immunosuppression mediated by T cell. Zhonghua Er Ke Za Zhi 2011;49:181-5.
4. Soleymaninejadian E, Pramanik K, Samadian E. Immunomodulatory properties of mesenchymal stem cells: Cytokines and factors. Am J Reprod Immunol 2012;67:1-8.
5. Dokić J, Tomić S, Cerović S, Todorović V, Rudolf R, Colić M. Characterization and immunosuppressive properties of mesenchymal stem cells from periapical lesions. J Clin Periodontol 2012;39:807-16.
6. Pricola KL, Kuhn NZ, Haleem-Smith H, Song Y, Tuan RS. Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem 2009;108:577-88.
7. Tülpar S, Poyrazoǧlu MH, Özbilge H, Baştuǧ F, Gündüz Z, Torun YA, et al. Modulation of inflammation by mesenchymal stem cell transplantation in peritoneal dialysis in rats. Ren Fail 2012;34:1317-23.
8. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-63.
9. Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, et al. Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 2009;30:589-97.
10. Shin DY, Kim KJ, Ku CR, Lee MK, Jee SI, Chung WY, et al. Different CXCR4 Expression according to various histologic subtype of papillary thyroid carcinoma. Endocr Pathol 2013 [Epub ahead of print].
11. Lee CC, Lai JH, Hueng DY, Ma HI, Chung YC, Sun YY, et al. Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma. Cancer Cell Int 2013;13:85.
12. Wang J, Wang J, Dai J, Jung Y, Wei CL, Wang Y, et al. A glycolytic mechanism regulating an angiogenic switch in prostate cancer. Cancer Res 2007;67:149-59.
13. Velasco-Velázquez M, Pestell RG. The CCL5/CCR5 axis promotes metastasis in basal breast cancer. Oncoimmunology 2013;2:e23660.
14. Nakagami H, Maeda K, Morishita R, Iguchi S, Nishikawa T, Takami Y, et al. Novel autologous cell therapy in ischemic limb disease through growth factor secretion by cultured adipose tissue-derived stromal cells. Arterioscler Thromb Vasc Biol 2005;25:2542-7.
15. Soria G, Ben-Baruch A. The inflammatory chemokines CCL2 and CCL5 in breast cancer. Cancer Lett 2008;267:271-85.
16. Klopp AH, Zhang Y, Solley T, Amaya-Manzanares F, Marini F, Andreeff M, et al. Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors. Clin Cancer Res 2012;18:771-82.
17. Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med 2011;17:1498-503.
18. Jeon ES, Moon HJ, Lee MJ, Song HY, Kim YM, Cho M, et al. Cancer-derived lysophosphatidic acid stimulates differentiation of human mesenchymal stem cells to myofibroblast-like cells. Stem Cells 2008;26:789-97.
19. Zhao BC, Zhao B, Han JG, Ma HC, Wang ZJ. Adipose-derived stem cells promote gastric cancer cell growth, migration and invasion through SDF-1/CXCR4 axis. Hepatogastroenterology 2010;57:1382-9.
20. Razmkhah M, Jaberipour M, Ghaderi A. Bcl-2 and Fas expressions correlate with proliferative specificity of adipose-derived stem cells (ASCs) in breast cancer. Immunol Invest 2011;40:290-8.
21. Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-β1 and upregulate expression of regulatory molecules on T cells: Do they protect breast cancer cells from the immune response? Cell Immunol 2011;266:116-22.
22. Musha H, Ohtani H, Mizoi T, Kinouchi M, Nakayama T, Shiiba K, et al. Selective infiltration of CCR5(+) CXCR3(+) T lymphocytes in human colorectal carcinoma. Int J Cancer 2005;116:949-56.
23. Lee TV, Kim DK, Peoples GE, Castilleja A, Murray JL, Gershenson DM, et al. Secretion of CXC chemokine IP-10 by peripheral blood mononuclear cells from healthy donors and breast cancer patients stimulated with HER-2 peptides. J Interferon Cytokine Res 2000;20:391-401.
24. Moriai S, Takahara M, Ogino T, Nagato T, Kishibe K, Ishii H, et al. Production of interferon-{gamma}-inducible protein-10 and its role as an autocrine invasion factor in nasal natural killer/T-cell lymphoma cells. Clin Cancer Res 2009;15:6771-9.
25. Goldberg-Bittman L, Neumark E, Sagi-Assif O, Azenshtein E, Meshel T, Witz IP, et al. The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol Lett 2004;92:171-8.
26. Fulton AM. The chemokine receptors CXCR4 and CXCR3 in cancer. Curr Oncol Rep 2009;11:125-31.
27. Sato E, Fujimoto J, Toyoki H, Sakaguchi H, Alam SM, Jahan I, et al. Expression of IP-10 related to angiogenesis in uterine cervical cancers. Br J Cancer 2007;96:1735-9.
28. Piper KP, Horlock C, Curnow SJ, Arrazi J, Nicholls S, Mahendra P, et al. CXCL10-CXCR3 interactions play an important role in the pathogenesis of acute graft-versus-host disease in the skin following allogeneic stem-cell transplantation. Blood 2007;110:3827-32.
29. Yang S, Wang B, Guan C, Wu B, Cai C, Wang M, et al. Foxp3+IL-17+T cells promote development of cancer-initiating cells in colorectal cancer. J Leukoc Biol 2011;89:85-91.
30. Shi Z, Okuno Y, Rifa'i M, Endharti AT, Akane K, Isobe K, et al. Human CD8+CXCR3+T cells have the same function as murine CD8+CD122+Treg. Eur J Immunol 2009;39:2106-19.
31. Akdis CA, Joss A, Akdis M, Blaser K. Mechanism of IL-10-induced T cell inactivation in allergic inflammation and normal response to allergens. Int Arch Allergy Immunol 2001;124:180-2.
32. Yaal-Hahoshen N, Shina S, Leider-Trejo L, Barnea I, Shabtai EL, Azenshtein E, et al. The chemokine CCL5 as a potential prognostic factor predicting disease progression in stage II breast cancer patients. Clin Cancer Res 2006;12:4474-80.
33. Chuang JY, Yang WH, Chen HT, Huang CY, Tan TW, Lin YT, et al. CCL5/CCR5 axis promotes the motility of human oral cancer cells. J Cell Physiol 2009;220:418-26.
34. Tang CH, Yamamoto A, Lin YT, Fong YC, Tan TW. Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis. Biochem Pharmacol 2010;79:209-17.